• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Intec Pharma to Present at Biotech Industry Conference

September 2, 2017

 

It's important to note whenever one of your current or prospective portfolio holdings is participating in major investor conferences. First and foremost, the increased awareness garnered by these conferences can move stock prices. Secondly, the companies participating usually have one of their top executives giving an overview of their company and what's to come.

 

Related: Intec Announces Secondary Offering To Fund Clinical Trials

 

Intec Pharma Ltd. (NASDAQ:NTEC) (TASE:NTEC) just announced that the company's management will be participating in BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference to be held on September 8, 2017 at the Millennium Broadway Hotel & Conference Center in New York City. John Kozarich, Ph.D., Chairman of the Board of Intec Pharma is expected to present on Friday, September 8, 2017 at 10:30 a.m. EST. For those who will be unable to attend this conference, Dr. Kozarich’s presentation will be webcast live and can be accessed on the Investor Relations section of the Intec’s website.

 

Related: Pharma Veteran Joins Intec's Board


While there will be a handful of other biotech companies participating in the conference, we'll be attending the conference to see what else we can learn about Intec Pharma. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. Currently, Intec's product pipeline includes two product candidates in clinical trial stages. The one we're most interested in learning more about is the company's AP-CBD/THC, an Accordion Pill containing cannabidiol (a.k.a. CBD) and tetrahydrocannabinol (a.k.a. THC), which is being developed for various indications including neuropathic pain and fibromyalgia.

 

Related: How Medical Marijuana Can Help Patients with Fibromyalgia

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Our Cannabinoid Biotech Updates newsletter focuses on biotech and pharmaceutical companies developing cannabinoid-based drugs like Intec Pharma. Our Israel Updates newsletter focuses on Israeli companies in the cannabis space. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.